Trials / Completed
CompletedNCT01563341
Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Does dual hemispheric stimulation of the subthalamic nucleus (STN) and fornix/hypothalamus potentially improve cognitive function in patients with Parkinsons disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Deep brain stimulation | Study will be utilizing multiple brain electrodes simultaneously. The study will require at least two electrodes to be placed in one cerebral hemisphere (one for motor improvement and one for potential cognitive implications). |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2023-10-18
- Completion
- 2023-10-18
- First posted
- 2012-03-26
- Last updated
- 2024-12-27
- Results posted
- 2024-12-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01563341. Inclusion in this directory is not an endorsement.